The global demand for Thrombophilia Testing Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020- 2026.
Thrombophilia is defined as an abnormality of blood coagulation that increases the risk of thrombosis. Along with this, thrombophilia testing is used to optimize the benefit or risk ratio of anticoagulant treatment. It is used by doctors to decide when and how to treat patients. Apart from this, thrombophilia testing includes a set of tests, such as factor V assay, prothrombin time (PT or PT-INR), fibrinogen level, complete blood count (CBC), platelet count, thrombin time, and bleeding time. Moreover, thrombophilia testing is expensive and has ethical ramifications.
The growing aging population and increasing use of advance technologies for thrombophilia testing across the globe is primarily driving the market growth. The various government associations have taken initiatives to raise awareness through events about various blood disorders that may leads to thrombophilia testing are again accelerating the market value. However, high cost associated with the thrombophilia testing is likely to hamper the market growth. Whereas, rising case of rare and chronic diseases are likely to create demand over the forecast period.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of thrombophilia testing.
The entire thrombophilia testing market has been sub-categorized into product type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product Type
- Automated Testing
- Semi-automated Testing
- Specialty Clinics
- Diagnostic Laboratories
This section covers regional segmentation which accentuates on current and future demand for thrombophilia testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Thrombophilia Testing Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the thrombophilia testing market include Abbott, Instrumentation Laboratory SpA, Johns Hopkins Medicine, LabCorp, Siemens and Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.